Table 3.
Parameter* | Estimate | Risk Ratio | p-value |
---|---|---|---|
Rates within the first two years post-transplant | |||
Time Since Transplant (per month) | −0.28 | 0.76 | <.0001 |
Time Since Transplant (per month2) | 0.01 | 1.01 | <.0001 |
LDLT (ref. = DDLT) | 0.19 | 1.21 | 0.147 |
Initial Biliary Complication = Stricture or Stricture + Leak (ref. = Leak only) | 0.26 | 1.30 | 0.045 |
Recipient Age (per 10 year increase) | 0.13 | 1.14 | 0.045 |
Recipient BMI (per unit increase) | 0.02 | 1.02 | 0.013 |
Recipient Diagnosis of HCV | 0.28 | 1.33 | 0.025 |
Rates beyond two years post-transplant | |||
Time Since Transplant (per month) | −0.02 | 0.98 | 0.024 |
LDLT (ref. = DDLT) | 1.05 | 2.85 | 0.064 |
Initial Biliary Complication = Stricture or Stricture + Leak (ref. = Leak only) | 1.07 | 2.90 | 0.019 |
At least 1 Roux Type Biliary Anastamosis (ref. = no Roux type) | 1.09 | 2.97 | 0.015 |
Following variables were tested in the models, but were not statistically significant: recipient sex, race, MELD, medical condition at transplant, encephalopathy, ascites, donor age, and number of arterial anastomoses.